Upstart vs Synchrony Financial: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Upstart Holdings Inc (UPST)

Q3 202619 Jun – 8 Oct 2026

▲2▼2

Upstart Q3: Strong Growth, But CEO Exit and Rate Risks Weigh

Strong Q2 results and return to profitability Upstart's Q2 revenue jumped 42% to $364.7 million, loan originations rose 50%, and the company returned to profitability. This showed the business can grow and make money even in a tough economy.
This is the core positive fundamental news that drove investor optimism during the period.
Bank charter and funding progress A national bank charter expected in early 2027 could lower funding costs. September loan volume hit $1.38 billion, new credit-union partners joined, and a $400 million securitization kept funding open.
These developments improve Upstart's funding model and growth prospects, key for a lending platform.
CEO departure and margin concerns The surprise exit of the CEO, declining take rates (the cut Upstart keeps from each loan), and margin worries hurt confidence. Analysts stayed cautious, with Loop Capital starting coverage at Hold.
Leadership uncertainty and profitability pressures are major negatives that weighed on the stock.
High interest rates threaten rate-sensitive model High inflation and interest rates could force further rate hikes, which would hurt Upstart's lending model because it relies on low rates to keep loan demand and funding costs favorable.
This macro risk directly challenges Upstart's core business and was a key overhang during the period.

September 202618 Aug – 8 Oct 2026

▲3

Upstart's loan demand and funding hold up as bank charter nears

Loan demand keeps growing Upstart's September loan volume rose to $1.38 billion, with daily originations up from August, and its credit-risk gauge improved slightly. More loans mean more fees for Upstart, which is why the stock jumped 6.2% on the news.
Shows the core demand trend that drives Upstart's revenue and the period's biggest price move.
New credit-union partners widen the platform Credit Union of Denver joined Upstart's network, and Commonwealth Credit Union expanded into home-equity lines and auto loans. Each new partner brings more loans onto Upstart's marketplace, supporting volume growth without Upstart lending the money itself.
New distribution partners are a fresh, concrete driver of future origination volume.
Funding pipeline stays open KBRA gave preliminary ratings to Upstart's 52nd securitization, a $400 million deal backed by loans made on its platform. This shows investors will still buy Upstart's loans, which Upstart needs to keep funding new originations.
Funding access is the key constraint on Upstart's growth, so a new securitization matters.
Bank charter is a costly bet still ahead Upstart has conditional approval for a national bank charter, targeted for early 2027, which could lower funding costs and reduce reliance on partners. For now it is a cost center with no benefit this year, and analysts remain cautious, with Loop Capital starting at Hold.
The charter is the biggest strategic swing factor, but its payoff is uncertain and still in the future.

Latest18 Aug – 8 Oct 2026

▲3

Upstart's loan demand and funding hold up as bank charter nears

Loan demand keeps growing Upstart's September loan volume rose to $1.38 billion, with daily originations up from August, and its credit-risk gauge improved slightly. More loans mean more fees for Upstart, which is why the stock jumped 6.2% on the news.
Shows the core demand trend that drives Upstart's revenue and the period's biggest price move.
New credit-union partners widen the platform Credit Union of Denver joined Upstart's network, and Commonwealth Credit Union expanded into home-equity lines and auto loans. Each new partner brings more loans onto Upstart's marketplace, supporting volume growth without Upstart lending the money itself.
New distribution partners are a fresh, concrete driver of future origination volume.
Funding pipeline stays open KBRA gave preliminary ratings to Upstart's 52nd securitization, a $400 million deal backed by loans made on its platform. This shows investors will still buy Upstart's loans, which Upstart needs to keep funding new originations.
Funding access is the key constraint on Upstart's growth, so a new securitization matters.
Bank charter is a costly bet still ahead Upstart has conditional approval for a national bank charter, targeted for early 2027, which could lower funding costs and reduce reliance on partners. For now it is a cost center with no benefit this year, and analysts remain cautious, with Loop Capital starting at Hold.
The charter is the biggest strategic swing factor, but its payoff is uncertain and still in the future.

July 202619 Jun – 13 Aug 2026

▲2▼1

Upstart's Q2 beat and bank charter offset rate and margin worries

Q2 earnings beat and return to profitability Upstart's second-quarter revenue rose 42% to $364.7 million, beating estimates, with loan originations up 50% to $4.2 billion and net income jumping 195% to $16.5 million. This return to profitability shows the core business is growing strongly, which pushes the stock up.
This is the main new positive event that directly lifted the stock and answers what is driving it now.
National bank charter approval Upstart received approval for a national bank charter and plans to launch its bank in early 2027. This should lower lending costs by cutting fees paid to third-party banks, improving future profits and making its loans more competitive, which supports the stock price.
This is a new regulatory milestone that changes Upstart's cost structure and future profitability.
High interest rates threaten lending model The Fed has held rates at 3.50%-3.75% through 2026 and inflation hit a three-year high in May, so analysts now expect rate hikes instead of cuts. Upstart's business relies on rate cuts to grow loan demand, so this is a major headwind that could stall its recovery and push the stock down.
This is the biggest external risk that could reverse Upstart's growth and explains why the stock is still volatile.
CEO departure and margin concerns linger Upstart's stock fell 19% in the first half of 2026 amid declining take rates and the surprise resignation of CEO Dave Girouard, who was replaced by co-founder Paul Gu. While Q2 results were strong, these concerns still weigh on investor confidence and cap gains.
This explains the negative backdrop that partially offsets the recent positive earnings and bank charter news.

19 Jun – 13 Aug 2026

▲2▼1

Upstart's Q2 beat and bank charter offset rate and margin worries

Q2 earnings beat and return to profitability Upstart's second-quarter revenue rose 42% to $364.7 million, beating estimates, with loan originations up 50% to $4.2 billion and net income jumping 195% to $16.5 million. This return to profitability shows the core business is growing strongly, which pushes the stock up.
This is the main new positive event that directly lifted the stock and answers what is driving it now.
National bank charter approval Upstart received approval for a national bank charter and plans to launch its bank in early 2027. This should lower lending costs by cutting fees paid to third-party banks, improving future profits and making its loans more competitive, which supports the stock price.
This is a new regulatory milestone that changes Upstart's cost structure and future profitability.
High interest rates threaten lending model The Fed has held rates at 3.50%-3.75% through 2026 and inflation hit a three-year high in May, so analysts now expect rate hikes instead of cuts. Upstart's business relies on rate cuts to grow loan demand, so this is a major headwind that could stall its recovery and push the stock down.
This is the biggest external risk that could reverse Upstart's growth and explains why the stock is still volatile.
CEO departure and margin concerns linger Upstart's stock fell 19% in the first half of 2026 amid declining take rates and the surprise resignation of CEO Dave Girouard, who was replaced by co-founder Paul Gu. While Q2 results were strong, these concerns still weigh on investor confidence and cap gains.
This explains the negative backdrop that partially offsets the recent positive earnings and bank charter news.

Synchrony Financial (SYF)

Q3 20269 Jul – 8 Oct 2026

▲2▼2

Synchrony's record growth offset by credit strain and regulatory risk

Record purchase volume and broad growth Synchrony posted record Q2 purchase volume of $49.8 billion, with growth in all five business lines, a 24.5% earnings beat, and raised 2026 guidance. The company also returned $950 million to shareholders.
This highlights the core positive operational and financial results that drove the quarter.
AI partnerships and CareCredit expansion Synchrony announced AI partnerships with OpenAI and expanded CareCredit into Stripe and Vetspire, signaling innovation and new distribution channels that could support future growth.
This points to strategic initiatives that may drive future performance and investor optimism.
Credit strain amid high inflation Inflation at 4.2% and over a quarter of customers with credit scores below 660 pushed delinquencies to an 18-year high, raising concerns about credit quality and potential loan losses.
This is a key risk factor that weighed on the stock and could pressure future earnings.
Slow revenue growth and regulatory threat Q2 revenue missed estimates, growing just 1.9%—the slowest among card peers—and shares fell. The Credit Card Competition Act, backed by Trump and Vance, threatens swipe fees, though passage remains unlikely.
This captures the revenue weakness and regulatory overhang that offset positive developments.

August 202616 Jul – 8 Oct 2026

▲2▼2

Synchrony's record card spending and CareCredit deals offset a revenue miss and looming swipe-fee threat

Record purchase volume points to stronger second-half earnings Synchrony's Q2 purchase volume hit a record $49.8 billion, up 8% from a year ago, with growth in all five business lines and co-branded cards up 23%. Management expects this spending to lift loan balances and earnings in the second half, a positive for the stock.
This is the core positive force behind SYF: more card spending should drive future revenue and profit.
CareCredit expands into Stripe and Vetspire payment platforms Synchrony plugged its CareCredit health-care card into Stripe's payment system and Vetspire's veterinary software, giving millions of cardholders and thousands of clinics easier ways to offer financing. More places to use the card means more transaction volume over time.
These partnerships are new distribution channels that can grow SYF's health-care lending and fee income.
Q2 revenue growth was the slowest among card peers Synchrony's Q2 revenue rose just 1.9% to $3.72 billion and missed analyst estimates by 0.7%, the weakest growth among six tracked card stocks. Even though profit beat expectations, the soft top line and a 2% share drop since reporting weigh on sentiment.
It is the main negative fundamental datapoint this period and explains recent share-price weakness.
Credit Card Competition Act gains political momentum Trump and Vance backed the Credit Card Competition Act, which would force big banks to offer at least two payment networks per card and could lower swipe fees. Synchrony, as a card issuer, would earn less on each transaction if it passes, though the industry still sees it as unlikely to become law.
This is a real regulatory risk that could pressure SYF's fee revenue if it advances.

Latest16 Jul – 8 Oct 2026

▲2▼2

Synchrony's record card spending and CareCredit deals offset a revenue miss and looming swipe-fee threat

Record purchase volume points to stronger second-half earnings Synchrony's Q2 purchase volume hit a record $49.8 billion, up 8% from a year ago, with growth in all five business lines and co-branded cards up 23%. Management expects this spending to lift loan balances and earnings in the second half, a positive for the stock.
This is the core positive force behind SYF: more card spending should drive future revenue and profit.
CareCredit expands into Stripe and Vetspire payment platforms Synchrony plugged its CareCredit health-care card into Stripe's payment system and Vetspire's veterinary software, giving millions of cardholders and thousands of clinics easier ways to offer financing. More places to use the card means more transaction volume over time.
These partnerships are new distribution channels that can grow SYF's health-care lending and fee income.
Q2 revenue growth was the slowest among card peers Synchrony's Q2 revenue rose just 1.9% to $3.72 billion and missed analyst estimates by 0.7%, the weakest growth among six tracked card stocks. Even though profit beat expectations, the soft top line and a 2% share drop since reporting weigh on sentiment.
It is the main negative fundamental datapoint this period and explains recent share-price weakness.
Credit Card Competition Act gains political momentum Trump and Vance backed the Credit Card Competition Act, which would force big banks to offer at least two payment networks per card and could lower swipe fees. Synchrony, as a card issuer, would earn less on each transaction if it passes, though the industry still sees it as unlikely to become law.
This is a real regulatory risk that could pressure SYF's fee revenue if it advances.

July 20269 Jul – 22 Aug 2026

▲2▼2

Synchrony's AI push and raised outlook offset credit and inflation worries

Inflation and subprime strain Inflation hit a 3-year high of 4.2%, squeezing lower-income households. With over a quarter of Synchrony's customers below 660 credit scores and delinquencies at an 18-year high, defaults could rise and spending could slow, pressuring the stock.
This is the core fundamental risk weighing on Synchrony's business and stock.
Q2 revenue miss Synchrony's Q2 revenue of $4.61 billion fell short of the $4.66 billion estimate, sending shares down 1.6%. The miss shows the company isn't growing as fast as expected, which can hold the stock back.
A concrete earnings miss that directly affects investor confidence and valuation.
OpenAI partnership for in-chat shopping Synchrony is working with OpenAI to let shoppers buy directly inside ChatGPT using store cards, and is talking to Anthropic and Google about similar deals. This could expand card usage and reach new customers, a long-term positive.
A new growth avenue that could boost demand for Synchrony's cards and services.
Q2 EPS beat and raised 2026 outlook Synchrony beat Q2 EPS estimates by 24.5% and raised the low end of its 2026 EPS guidance to $9.25–$9.50. Loan receivables and purchase volume grew, and the company returned $950 million to shareholders, signaling financial strength.
Strong earnings and improved guidance directly support the stock price.

9 Jul – 22 Aug 2026

▲2▼2

Synchrony's AI push and raised outlook offset credit and inflation worries

Inflation and subprime strain Inflation hit a 3-year high of 4.2%, squeezing lower-income households. With over a quarter of Synchrony's customers below 660 credit scores and delinquencies at an 18-year high, defaults could rise and spending could slow, pressuring the stock.
This is the core fundamental risk weighing on Synchrony's business and stock.
Q2 revenue miss Synchrony's Q2 revenue of $4.61 billion fell short of the $4.66 billion estimate, sending shares down 1.6%. The miss shows the company isn't growing as fast as expected, which can hold the stock back.
A concrete earnings miss that directly affects investor confidence and valuation.
OpenAI partnership for in-chat shopping Synchrony is working with OpenAI to let shoppers buy directly inside ChatGPT using store cards, and is talking to Anthropic and Google about similar deals. This could expand card usage and reach new customers, a long-term positive.
A new growth avenue that could boost demand for Synchrony's cards and services.
Q2 EPS beat and raised 2026 outlook Synchrony beat Q2 EPS estimates by 24.5% and raised the low end of its 2026 EPS guidance to $9.25–$9.50. Loan receivables and purchase volume grew, and the company returned $950 million to shareholders, signaling financial strength.
Strong earnings and improved guidance directly support the stock price.